Genus Capital Management »

Dex shares owned by Genus Capital Management

Quarter-by-quarter ownership of Dex (DXCM) shares owned by Genus Capital Management from 13F filings

Historical chart of Genus Capital Management investment in Dex

Tip: Access up to 7 years of quarterly data

All positions including Dex held by Genus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dex by Genus Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.7M 34k 138.70
2023-12-31 $3.7M 30k 124.09
2023-09-30 $1.2M 12k 93.30

More positions owned by Genus Capital Management

NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Merck & Co (MRK)
Acuity Brands (AYI)
Ishares Tr Core Us Aggbd Et (AGG)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Ishares Tr Us Treas Bd Etf (GOVT)
Canadian Natl Ry (CNI)
Sprouts Fmrs Mkt (SFM)
Celestica Sub Vtg Shs (CLS)
Microsoft Corporation (MSFT)
Edwards Lifesciences (EW)
Kinross Gold Corp (KGC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Genus Capital Management

Top funds holding Dex

Vanguard Group
BlackRock
Baillie Gifford & Co
Sands Capital Management
FMR
Geode Capital Management
Nuveen Asset Management
Artisan Partners Limited Partnership
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
American Century Companies
Morgan Stanley
William Blair $ Company
Ubs Global Asset Management Americas
Bank of New York Mellon

View all funds holding Dex